| Name | Graft Polymer (UK) |
|---|---|
| Epic | GPL |
| Isin | GB00BMD1Z199 |
| Industry | Pharmaceuticals & Biotechnology |
| Latest share price | 0.17p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £3.79 | Debt ratio | n/a |
| Shares in issue | 2,295.93 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | 38962.21 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -3 | 52-week high / low | 0.12p / 1.01p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Graft Polymer (UK) |
|---|---|
| Address | Eccleston Yards, 25 Eccleston Place, London, United Kingdom, SW1W 9NF |
| Telephone | +44 (0)20 4524 9900 |
| Website | http:// www.graftpolymer.com |
| Director | Position |
|---|---|
| Mr Anthony Tennyson | CEO |
| Mr Dennis Purcell | Chairman |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | 2.07 | 2.07 | 2.07 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 2.12 | 2.78 | 2.39 |
| Inventory / work in progress | 0.05 | 0.19 | n/a |
| Trade and other receivables | 0.11 | 0.33 | 0.14 |
| Cash and equivalents | 0.15 | 1.64 | 0.6 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 2.43 | 4.94 | 3.13 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 0.39 | 0.37 | 2.32 |
| Long term liabilities | 0.02 | 0.02 | n/a |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 0.41 | 0.39 | 2.32 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 2.03 | 4.55 | 0.81 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 0.04 | 0.04 | 0.01 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -8.96 | -5.84 | -3.14 |
| Share premium account | 7 | 7 | 0.94 |
| Total equity | 2.03 | 4.55 | 0.81 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -3.12 | -2.7 | -0.95 |
| Pre-tax profit | -3.12 | -2.71 | -0.95 |